Is the administration of vancomycin to operative field effective? Studying from operative wound drainage tube culture.


Journal

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie
ISSN: 1432-1068
Titre abrégé: Eur J Orthop Surg Traumatol
Pays: France
ID NLM: 9518037

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 15 05 2019
accepted: 09 10 2019
pubmed: 13 10 2019
medline: 18 11 2020
entrez: 13 10 2019
Statut: ppublish

Résumé

To investigate the efficacy of application of VCM powder to surgical wounds. A total of 314 patients who underwent posterior spinal instrumentation with local application of VCM (VCM group) were compared to 354 patients without VCM (control). The wound drainage tube was submitted for bacterial culture. The number of positive cultures, types of bacteria, and incidence of surgical site infections (SSI) were investigated. Drainage tube culture was positive in 1.6% (5/314 cases) and 7.3% (26/354 cases) of the VCM and control groups, respectively (P = 0.004). Among the five positive cases in the VCM group, one had an SSI, compared to three of 26 in the control group. Among the culture-negative cases, 0 and six, respectively, had an SSI. Finally, the incidence of SSI was 0.3% (1/314 cases) and 2.5% (9/354 cases), respectively. SSI occurred significantly less often in the VCM than in the control group (P = 0.01). The pathogenic bacterium was P. aeruginosa in the VCM group and MSSE, S. marcescens, methicillin-resistant S. aureus (MRSA), etc., in the control group. This study indicates that the amount of bacteria in the operative field was decreased by local application of VCM. However, the incidence of positive culture of VCM-resistant bacteria was not decreased by VCM. Importantly, pathogenic bacteria in the VCM group were only VCM-resistant, supporting the efficacy of VCM. In conclusion, local application of VCM decreases the amount of bacteria in the operative field and leads to fewer SSIs.

Identifiants

pubmed: 31605209
doi: 10.1007/s00590-019-02579-0
pii: 10.1007/s00590-019-02579-0
doi:

Substances chimiques

Anti-Bacterial Agents 0
Powders 0
Vancomycin 6Q205EH1VU

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

215-219

Références

Orthop Clin North Am. 1972 Mar;3(1):99-111
pubmed: 5012590
J Spinal Disord. 2000 Oct;13(5):422-6
pubmed: 11052352
Neurosurgery. 2017 May 1;80(5):746-753
pubmed: 28387851
J Orthop Sci. 2015 Jan;20(1):38-54
pubmed: 25477013
Spine (Phila Pa 1976). 1998 Feb 1;23(3):366-70
pubmed: 9507627
J Thorac Cardiovasc Surg. 2002 Feb;123(2):326-32
pubmed: 11828293
Orthop Clin North Am. 1996 Jan;27(1):171-82
pubmed: 8539047
Neurosurg Focus. 2015 Oct;39(4):E11
pubmed: 26424335
Eur Spine J. 2012 Jun;21 Suppl 4:S476-82
pubmed: 22160172
Spine (Phila Pa 1976). 2016 Jul 15;41(14):1179-84
pubmed: 26890956
Spine (Phila Pa 1976). 2013 Dec 1;38(25):2149-55
pubmed: 24048091
Spine (Phila Pa 1976). 2011 Nov 15;36(24):2084-8
pubmed: 21304438
Int Orthop. 2004 Oct;28(5):311-4
pubmed: 15316674
Spine (Phila Pa 1976). 2017 Feb 15;42(4):267-274
pubmed: 28207669

Auteurs

Hirohito Takeuchi (H)

Department of Spine Surgery, Hokkaido Orthopedic Memorial Hospital, 7-13, Hiragishi, Toyohiraku, Sapporo City, Hokkaido Prefecture, 062-0937, Japan. htakeuch1972@gmail.com.

Itaru Oda (I)

Department of Spine Surgery, Hokkaido Orthopedic Memorial Hospital, 7-13, Hiragishi, Toyohiraku, Sapporo City, Hokkaido Prefecture, 062-0937, Japan.

Shigeki Oshima (S)

Department of Spine Surgery, Hokkaido Orthopedic Memorial Hospital, 7-13, Hiragishi, Toyohiraku, Sapporo City, Hokkaido Prefecture, 062-0937, Japan.

Masaru Suzuki (M)

Department of Spine Surgery, Hokkaido Orthopedic Memorial Hospital, 7-13, Hiragishi, Toyohiraku, Sapporo City, Hokkaido Prefecture, 062-0937, Japan.

Masanori Fujiya (M)

Department of Spine Surgery, Hokkaido Orthopedic Memorial Hospital, 7-13, Hiragishi, Toyohiraku, Sapporo City, Hokkaido Prefecture, 062-0937, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH